Obesity Is Associated With Family History of ESRD in Incident Dialysis Patients

American Journal of Kidney Diseases

Volumn 48, Issue 1, 2006, Pages 50-58

  Speckman, Rebecca A ^a,b,c,d   McClellan, William M ^a,b,c,d   Volkova, Nataliya V ^a,b,c,d   Jurkovitz, Claudine T ^a,b,c,d   Satko, Scott G ^a,b,c,d   Schoolwerth, Anton C ^a,b,c,d   Freedman, Barry I ^a,b,c,d  

^a EMORY UNIVERSITY   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

End stage renal disease; familial clustering; family history; obesity

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FAMILY HISTORY; FEMALE; HUMAN; INCIDENCE; INFORMATION PROCESSING; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OBESITY; PATHOGENESIS; RACE; RENAL REPLACEMENT THERAPY; RISK FACTOR; SEX RATIO;

ADULT; AGED; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OBESITY; PEDIGREE; RENAL DIALYSIS; RISK FACTORS;

EID: 33745183809     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2006.03.086     Document Type: Article

References (45)

1. Ferguson R., Grim C.E., and Opgenorth T.J. A familial risk of chronic renal failure among blacks on dialysis?. J Clin Epidemiol 41 (1998) 1189-1196
2. Freedman B.I., Soucie J.M., and McClellan W.M. Family history of end-stage renal disease among incident dialysis patients. J Am Soc Nephrol 8 (1997) 1942-1945
3. Freedman B.I., Volkova N.V., Satko S.G., et al. Population-based screening for family history of end-stage renal disease among incident dialysis patients. Am J Nephrol 25 (2005) 529-535
4. Gumprecht J., Zychma M.J., Moczulski D.K., Gosek K., and Grzeszczak W. Family history of end-stage renal disease among hemodialyzed patients in Poland. J Nephrol 16 (2003) 511-515
5. Nelson R.G., Knowler W.C., McCance D.R., et al. Determinants of end-stage renal disease in Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus and proteinuria. Diabetologia 36 (1993) 1087-1093
6. Canani L.H., Gerchman F., and Gross J.L. Familial clustering of diabetic nephropathy in Brazilian type 2 diabetic patients. Diabetes 48 (1999) 909-913
7. Chandie Shaw P.K., van Es L.A., Paul L.C., Rosendaal F.R., Souverijn J.H., and Vandenbroucke J.P. Renal disease in relatives of Indo-Asian type 2 diabetic patients with end-stage diabetic nephropathy. Diabetologia 46 (2003) 618-624
8. Weisinger J.R., Kempson R.L., Eldridge F.L., and Swenson R.S. The nephrotic syndrome. A complication of massive obesity. Ann Intern Med 81 (1974) 440-447
9. Kasiske B.L., and Crosson J.T. Renal disease in patients with massive obesity. Arch Intern Med 146 (1986) 1105-1109
10. Jennette J.C., Charles L., and Grubb W. Glomerulomegaly and focal segmental glomerulosclerosis associated with obesity and sleep-apnea syndrome. Am J Kidney Dis 10 (1987) 470-472
11. Kasiske B.L., and Napier J. Glomerular sclerosis in patients with massive obesity. Am J Nephrol 5 (1985) 45-50
12. Stengel B., Tarver-Carr M.E., Powe N.R., Eberhardt M.S., and Brancati F.L. Lifestyle factors, obesity and the risk of chronic kidney disease. Epidemiology 14 (2003) 479-487
13. Fox C.S., Larson M.G., Leip E.P., Culleton B., Wilson P.W., and Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA 291 (2004) 844-850
14. Vupputuri S., and Sandler D.P. Lifestyle risk factors and chronic kidney disease. Ann Epidemiol 13 (2003) 712-720
15. Burns T.L., Moll P.P., and Lauer R.M. The relation between ponderosity and coronary risk factors in children and their relatives. The Muscatine Ponderosity Family Study. Am J Epidemiol 129 (1989) 973-987
16. Ayatollahi S.M. Obesity in school children and their parents in southern Iran. Int J Obes Relat Metab Disord 16 (1992) 845-850
17. Guillaume M., Lapidus L., Beckers F., Lambert A., and Bjorntorp P. Familial trends of obesity through three generations. The Belgian-Luxembourg child study. Int J Obes Relat Metab Disord 19 suppl 3 (1995) S5-S9
18. Magnusson P.K., and Rasmussen F. Familial resemblance of body mass index and familial risk of high and low body mass index. A study of young men in Sweden. Int J Obes Relat Metab Disord 26 (2002) 1225-1231
19. Fuentes R.M., Notkola I.L., Shemeikka S., Tuomilehto J., and Nissinen A. Familial aggregation of body mass index. A population-based family study in eastern Finland. Horm Metab Res 34 (2002) 406-410
20. Mirmiran P., Mirbolooki M., and Azizi F. Familial clustering of obesity and the role of nutrition. Tehran Lipid and Glucose Study. Int J Obes Relat Metab Disord 26 (2002) 1617-1622
21. Freedman B.I., Langefeld C.D., Rich S.S., et al. A genome scan for end-stage renal disease in African American families enriched for non-diabetic nephropathy. J Am Soc Nephrol 15 (2004) 2719-2727
22. World Health Organization. Obesity. Preventing and Managing the Global Epidemic. Report from a WHO Consultation. Geneva, Switzerland, World Health Organization, WHO Technical Report Series 894 (2000)
23. Levey A.S., Greene T., Kusek J.W., Beck G.L., and MDRD Study Group. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 11 (2000) 155A abstr
24. Spray B.J., Atassi N.G., Tuttle A.B., and Freedman B.I. Familial risk, age at onset, and cause of end-stage renal disease in white Americans. J Am Soc Nephrol 5 (1995) 1806-1810
25. Watson Jr. B., Khan M.A., Desmond R.A., and Bergman S. Mitochondrial DNA mutations in black Americans with hypertension-associated end-stage renal disease. Am J Kidney Dis 38 (2001) 529-536
26. Hong Y., Rice T., Gagnon J., et al. Familial clustering of insulin and abdominal visceral fat. The HERITAGE Family Study. J Clin Endocrinol Metab 83 (1998) 4239-4245
27. Davey G., Ramachandran A., Snehalatha C., Hitman G.A., and McKeigue P.M. Familial aggregation of central obesity in Southern Indians. Int J Obes Relat Metab Disord 24 (2000) 1523-1527
28. Snyder E.E., Walts B., Perusse L., et al. The human obesity gene map. The 2003 update. Obes Res 12 (2004) 369-439
29. Davison K.K., and Birch L.L. Child and parent characteristics as predictors of change in girls' body mass index. Int J Obes Relat Metab Disord 25 (2001) 1834-1842
30. Pinto-Sietsma S.J., Navis G., Janssen W.M., de Zeeuw D., Gans R.O., de Jong P.E., and PREVEND Study Group. A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis 41 (2003) 733-741
31. Bosma R.J., van der Heide J.J., Oosterop E.J., de Jong P.E., and Navis G. Body mass index is associated with altered renal hemodynamics in non-obese healthy subjects. Kidney Int 65 (2004) 259-265
32. Schelling J.R., and Sedor J.R. The metabolic syndrome as a risk factor for chronic kidney disease. More than a fat chance?. J Am Soc Nephrol 15 (2004) 2773-2774
33. Hall J.E., Henegar J.R., Dwyer T.M., et al. Is obesity a major cause of chronic kidney disease?. Adv Ren Replace Ther 11 (2004) 41-54
34. Abrass C.K. Overview: Obesity: What does it have to do with kidney disease?. J Am Soc Nephrol 15 (2004) 2768-2772
35. Bagby S.P. Obesity-initiated metabolic syndrome and the kidney. A recipe for chronic kidney disease?. J Am Soc Nephrol 15 (2004) 2775-2791
36. Wisse B.E. The inflammatory syndrome. The role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 15 (2004) 2792-2800
37. Pereira A.C., Pereira A.B., Mota G.F., et al. NPHS2 R229Q functional variant is associated with microalbuminuria in the general population. Kidney Int 65 (2004) 1026-1030
38. McClellan W.M., Ramirez S.P., and Jurkovitz C. Screening for chronic kidney disease. Unresolved issues. J Am Soc Nephrol 14 suppl 2 (2003) S81-S87
39. Satko S.G., and Freedman B.I. The importance of family history on the development of renal disease. Curr Opin Nephrol Hypertens 13 (2004) 337-341
40. Boulware L.E., Jaar B.G., Tarver-Carr M.E., Brancati F.L., and Powe N.R. Screening for proteinuria in US adults. A cost-effectiveness analysis. JAMA 290 (2003) 3101-3114
41. Chagnac A., Weinstein T., Herman M., Hirsh J., Gafter U., and Ori Y. The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 14 (2003) 1480-1486
42. Maddox D.A., Alavi F.K., Santella R.N., and Zawada Jr. E.T. Prevention of obesity-linked renal disease. Age-dependent effects of dietary food restriction. Kidney Int 62 (2002) 208-219
43. Velasquez M.T., Bhathena S.J., Ranich T., et al. Dietary flaxseed meal reduces proteinuria and ameliorates nephropathy in an animal model of type II diabetes mellitus. Kidney Int 64 (2003) 2100-2107
44. National Kidney Disease Education Program: Family Reunion Initiative. Available at: www.nkdep.nih.gov/familyreunion. Accessed November 1, 2005
45. Fan Z.J., Lackland D.T., Kenderes B., Krisher J., and Freedman B.I. Impact of birth weight on familial aggregation of end-stage renal disease. Am J Nephrol 23 (2003) 117-120